Christopher Tompkins

KromaTid, Inc. provides products and services for mutation detection and disease diagnosis. Its services include high resolution screening of individual genes to the entire genome, sequence, location and orientation from a single assay, cost effective discovery of inversions and translocations, rapid assay development and data delivery. The company was founded by Andrew F. Ray, Susan M. Bailey, Michael Cornforth, Edwin Goodwin, and Joel S. Bedford in 2007 and is headquartered in Longmont, CO.

Eveia Medical, Inc. provides medical and research diagnostics services. The firm’s product is the EVEIA bioanalytical system. Its product includes instrumentation, software, and the consumables required for automated analyte measurement and disease state identification. The company is headquartered in Boulder, CO.